Syngene Q2 profit drops 37% as biologics correction offsets growth​

Revenue up 2% YoY to Rs 926 crore as research services offset biologics inventory correction; company maintains FY26 guidance

​ 

author avatar
peoplic.com

Leave a Reply

Your email address will not be published. Required fields are marked *

0 Comments
scroll to top